VialVIAL
Vial Confidence Comparison
VialVIAL

Embody vs Saguaro Medical Weight Control, Semaglutide, Phentermine

Same category. Different operational transparency.

SignalEmbodySaguaro Medical Weight Control, Semaglutide, Phentermine
Pharmacy Disclosure
Do they name their pharmacy partner?
No pharmacy partner named
No pharmacy partner named
Physician Oversight
Are prescribing clinicians named?
No clinician disclosure
Team described in aggregate
Pricing Transparency
Is pricing shown before signup?
Pricing not disclosed
Pricing not disclosed
Federal Enforcement History
Any FDA, DEA, or OIG actions?
No federal actions found
No federal actions found
State Availability
How widely is care available?
Coverage not disclosed
1 states
Membership Model
Is a paid membership required?
No membership required
No membership required
Data & Privacy
Any reported HIPAA breaches?
No breaches on record
No breaches on record
Lower Vial Score
Embody
Gaps in pharmacy disclosure, physician oversight, and pricing.
Higher Vial Score
Saguaro Medical Weight Control, Semaglutide, Phentermine
Leads on physician oversight and state availability.
Updated August 29, 2026
Scores based on operational, compliance, and transparency signals tracked by Vial.
getvial.com

Biggest Differences

  1. Vial Score gap (26 points)
    Saguaro Medical Weight Control, Semaglutide, Phentermine scores 76/100 to Embody's 50/100, a 26-point spread driven by the differences below.
Vial Analysis

Our Assessment

What separates the two on the public record.

  • Vial Score
    Embody scores 50, Saguaro Medical Weight Control, Semaglutide, Phentermine scores 76.
  • Provider type
    Embody is a telehealth platform; Saguaro Medical Weight Control, Semaglutide, Phentermine is a clinic / medical practice.

Comparison reflects publicly disclosed federal and state records only. Vial does not audit clinical quality or patient outcomes.

Provider A

Embody

Provider B

Saguaro Medical Weight Control, Semaglutide, Phentermine

DeliveryIn-Person Only
HQPhoenix, AZ
Services: Weight Loss, GLP-1

Comparison based on public federal and state records including NPI Registry, FDA enforcement database, and PCAB accreditation directory. Updated weekly. Not a medical endorsement.

What’s next

Make your next move

Share this comparison

This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.